Transient immunomodulation allows repeated injections of AAV1 and correction of muscular dystrophy in multiple muscles. (Q53775896)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18180780%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Transient immunomodulation allows repeated injections of AAV1 and correction of muscular dystrophy in multiple muscles (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18180780%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18180780%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

David Gross

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18180780%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Aurélie Goyenvalle

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18180780%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jean Davoust

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18180780%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Olivier Danos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18180780%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Luis Garcia

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18180780%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

8 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18180780%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18180780%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18180780%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18180780%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

541-547

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18180780%20AND%20SRC:MED&resulttype=core&format=json

Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Treatment of human disease by adeno-associated viral gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Genetic fate of recombinant adeno-associated virus vector genomes in muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Recombinant adeno-associated virus for muscle directed gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

CD8(+) T-cell responses to adeno-associated virus capsid in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Determination of specific CD4 and CD8 T cell epitopes after AAV2- and AAV8-hF.IX gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Identification of mouse AAV capsid-specific CD8+ T cell epitopes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Characterization of tissue tropism determinants of adeno-associated virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Somatic reversion/suppression of the mouse mdx phenotype in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

The "rescue" of dystrophin synthesis in boys with Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Noninvasive monitoring of therapeutic gene transfer in animal models of muscular dystrophies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Genetic and structural determinants of virus neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Immune responses to adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Directed evolution of adeno-associated virus yields enhanced gene delivery vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Combinatorial engineering of a gene therapy vector: directed evolution of adeno-associated virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

CTLA4Ig: a novel inhibitor of costimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Short-term immunosuppression facilitates induction of mixed chimerism and tolerance after bone marrow transplantation without cytoreductive conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Immunomodulation of transgene responses following naked DNA transfer of human factor VIII into hemophilia A mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Femoral intra-arterial injection: a tool to deliver and assess recombinant AAV constructs in rodents whole hind limb

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300377

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300377

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18180780%20AND%20SRC:MED&resulttype=core&format=json

release_g2wz3mz7k5a4xfkwfv5xbug7nu

31 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/g2wz3mz7k5a4xfkwfv5xbug7nu

24 November 2022

mapped directly with Wikidata item

1 reference